Therapeutic compositions containing glutathione analogs

Details Therapeutic compositions containing glutathione analogs Therapeutic compositions containing glutathione analogs

2006-04-18

2006-04-18

Kishore, Gollamudi S. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

C514S018700, C530S331000

Reexamination Certificate

active

07029695

ABSTRACT:
Pharmaceutical compositions and methods of using them. Lipid formulations of a glutathione analog and methods of manufacturing them. Their use to stimulate hematopoiesis, protect hematopoietic cells from damage caused by radiation or chemotherapy, or potentiate the stimulatory action of one or a combination of cytokines on colony formation by hematopoietic progenitor cells, protect a subject from a destructive effect of a chemotherapeutic agent or irradiation, or to potentiate the effect of a chemotherapeutic agent.

REFERENCES:
patent: 4944948 (1990-07-01), Uster et al.
patent: 5023087 (1991-06-01), Yau-Young
patent: 5043166 (1991-08-01), Barenholz et al.
patent: 5415869 (1995-05-01), Straubinger et al.
patent: 5605703 (1997-02-01), Lambiez et al.
patent: 5679643 (1997-10-01), Kauvar et al.
patent: 5955432 (1999-09-01), Kauvar et al.
patent: 1 072 608 (2001-01-01), None
patent: 95/08563 (1995-03-01), None
patent: 96/40205 (1996-12-01), None
patent: WO 00/44366 (2000-08-01), None
Ciaccio P. J. et al, “Modulation of Detoxification Gene Expression in Human Colon HT29 Cells by Glutathione-S-Transferase Inhibitors”, Molecular Pharmacology, vol. 48, No. 4, Oct. 1, 1995, pp. 639-647.
Morgan A. S. et al., “Isozyme-Specific Glutathione S-Transferase Inhibitors Potentiate Drug Sensitivity in Cultured Human Tumor Cell Lines”, Cancer Chemotherapy and Pharmacology, vol. 37, No. 4, 1996, pp. 363-370.
Schultz, M. et al., “Inhibitors Of Glutathione S-Transferase As Therapeutic Agents”, Advanced Drug Delivery Reviews, vol. 26, No. 2/03, Jul. 1, 1997, pp. 91-104.
Z. Pavelic et al., “Development in vitro evaluation of a liposomal vaginal delivery system for acyclovir”, Poster Abstract; Apr. 1, 2003; obtained from http://www.dekker.com/servlet/product/DOI/101081LPR120017490/section/abstract—38.
R.J.H. Stenekes et al., “Degradable dextran microspheres for the controlled release of liposomes”,Int. J. Pharmaceutics, 214, 17-20 (2001).
D. Reimer et al., “Cyclosporin (CSA) release from microemulsion: effect of membrane apposition”, CSPS 5thSymposium on Pharmaceutical Sciences '02,J. Pharm. Pharmaceut. Sci. (www.ualberta.ca/˜csps), 5(2), 39-122 (2002).

Affiliated with

Also associated with

Rating

Therapeutic compositions containing glutathione analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic compositions containing glutathione analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compositions containing glutathione analogs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3553745